EA201991504A1 - Композиции на основе аминокислот и способы лечения заболеваний и нарушений мышц - Google Patents

Композиции на основе аминокислот и способы лечения заболеваний и нарушений мышц

Info

Publication number
EA201991504A1
EA201991504A1 EA201991504A EA201991504A EA201991504A1 EA 201991504 A1 EA201991504 A1 EA 201991504A1 EA 201991504 A EA201991504 A EA 201991504A EA 201991504 A EA201991504 A EA 201991504A EA 201991504 A1 EA201991504 A1 EA 201991504A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
muscles
disorders
amino acids
treating diseases
Prior art date
Application number
EA201991504A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/067368 external-priority patent/WO2018118957A1/en
Publication of EA201991504A1 publication Critical patent/EA201991504A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Настоящее изобретение предусматривает композиции, содержащие структурные единицы на основе аминокислоты. Настоящее изобретение также предусматривает способы повышения функции мышцы, предусматривающие введение эффективного количества композиций субъекту, нуждающемуся в этом.
EA201991504A 2017-10-24 2017-12-19 Композиции на основе аминокислот и способы лечения заболеваний и нарушений мышц EA201991504A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762576321P 2017-10-24 2017-10-24
PCT/US2017/067368 WO2018118957A1 (en) 2016-12-19 2017-12-19 Amino acid compositions and methods for the treatment of muscle diseases and disorders

Publications (1)

Publication Number Publication Date
EA201991504A1 true EA201991504A1 (ru) 2019-11-29

Family

ID=68653577

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201991504A EA201991504A1 (ru) 2017-10-24 2017-12-19 Композиции на основе аминокислот и способы лечения заболеваний и нарушений мышц

Country Status (1)

Country Link
EA (1) EA201991504A1 (ru)

Similar Documents

Publication Publication Date Title
PH12019501339A1 (en) Amino acid compositions and methods for the treatment of muscle diseases and disorders
PH12019501414A1 (en) Amino acid compositions and methods for the treatment of liver diseases
EA201790273A1 (ru) Флагеллиновые композиции и их применение
EA201792573A1 (ru) Триспецифические связанные белки и способы их применения
EA201991720A1 (ru) Антитела к альфа-синуклеину и их применения
CO2020001702A2 (es) Composiciones de aminoácidos para el tratamiento de enfermedad hepática
EA201790142A1 (ru) Лечение лейкоза ингибиторами гистондеацетилазы
MX2023007212A (es) Formulaciones de pulverizacion de epinefrina.
EA201891727A1 (ru) Композиции на основе дейтерированного домперидона и способы терапии расстройств
EA202091020A1 (ru) Замещенные имидазопиридинамиды и их применение
EA202091482A1 (ru) Антитела
EA201790336A1 (ru) Антитела к ангиопоэтинподобному белку 4 и способы применения
EA201892297A1 (ru) Способы лечения холестатических и фибротических заболеваний
EA202091478A1 (ru) Антитела
EA201591507A1 (ru) Лечение рассеянного склероза лахинимодом
EA202191446A1 (ru) Композиции для улучшения сексуальной функции
MX2018014129A (es) Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato.
EA202092045A1 (ru) Лечение и предупреждение преэклампсии
WO2015188198A3 (en) Methods of treating a metabolic syndrome by modulating heat shock protein (hsp) 90-beta
EA201991504A1 (ru) Композиции на основе аминокислот и способы лечения заболеваний и нарушений мышц
EA202190626A2 (ru) Комбинация тразодона и габапентина для лечения боли
EA201991395A1 (ru) Новые композиции для лечения суставных нарушений
EA202091524A1 (ru) Ингибиторы рецептора, активируемого протеазой 2
EA201991502A1 (ru) Композиции на основе аминокислот и способы лечения заболеваний печени
EA201592012A8 (ru) Применение флагеллина для улучшенной химиотерапии